Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05112510
What this trial is testing

Prognostic Prediction of NPC Based on MR Diffusion-weighted Imaging

Who this might be right for
Patients With Nasopharyngeal Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University 125
Not applicableUnknownNCT00563927
What this trial is testing

Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)

Who this might be right for
Nasopharyngeal NeoplasmsCarcinoma, Squamous Cell
Hospital Authority, Hong Kong 340
Not applicableLooking for participantsNCT07137052
What this trial is testing

Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)PET / CT
The First Affiliated Hospital of Xiamen University 732
Testing effectiveness (Phase 2)Study completedNCT03906058
What this trial is testing

Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 39
Not applicableNot Yet RecruitingNCT07062484
What this trial is testing

A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Lung Metastatic Nasopharyngeal Carcinoma
Sichuan Cancer Hospital and Research Institute 600
Not applicableUnknownNCT01210872
What this trial is testing

Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy

Who this might be right for
Head and Neck Cancer
Centre Georges Francois Leclerc 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07252375
What this trial is testing

A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)CTIT-Chemotherapy Induced Thrombocytopenia
Fujian Cancer Hospital 35
Testing effectiveness (Phase 2)UnknownNCT01171781
What this trial is testing

Phase II Study of Concurrent Chemoradiation With Every 3 Week of Cisplatin vs With Weekly Cisplatin in Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasophayngeal Carcinoma Between Stage II and IVb
Samsung Medical Center 110
Testing effectiveness (Phase 2)Study completedNCT02562599
What this trial is testing

Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin

Who this might be right for
Nasopharyngeal Carcinoma
Hubei Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT02523430
What this trial is testing

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fuda Cancer Hospital, Guangzhou 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07797881
What this trial is testing

BL-B01D1 With or Without PD-1 Monoclonal Antibody in Patients With High-Risk Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sichuan Baili Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Looking for participantsNCT07277764
What this trial is testing

Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasopharyngeal Carcinoma (Single-Arm Phase II)

Who this might be right for
Nasopharyngeal Carcinoma (NPC)Recurrent Nasopharyngeal Neoplasms
Jiangxi Provincial Cancer Hospital 23
Testing effectiveness (Phase 2)UnknownNCT04072107
What this trial is testing

EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR)

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 110
Not applicableUnknownNCT02627807
What this trial is testing

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 386
Testing effectiveness (Phase 2)Active Not RecruitingNCT03734809
What this trial is testing

NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer

Who this might be right for
NPC
Chinese University of Hong Kong 43
Testing effectiveness (Phase 2)Study completedNCT00063895
What this trial is testing

Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Non-small Cell Lung CancerRecurrent Ovarian Epithelial CancerRecurrent Squamous Cell Carcinoma of the Hypopharynx+27 more
National Cancer Institute (NCI) 80
Large-scale testing (Phase 3)UnknownNCT02958111
What this trial is testing

Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 406
Not applicableUnknownNCT06301672
What this trial is testing

Effect of Oral Enteral Nutrition in Nasopharyngeal Carcinoma Survivors With Swallowing Disorders

Who this might be right for
Dysphagia
Muhammad 60
Testing effectiveness (Phase 2)Study completedNCT00095901
What this trial is testing

Capecitabine For Nasopharyngeal Cancer

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 3
Testing effectiveness (Phase 2)Study completedNCT02309437
What this trial is testing

Early Use of Opioid in Radiation Mucositis

Who this might be right for
Nutrition DisordersQuality of Life
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 200
Next Page